Tuesday, March 1, 2016

"Fleming's discovery of penicillin couldn't get published today. That's a huge problem."

"Blattman asked himself some simple but profound questions: Was all this work on a single study really worth it? Was it best to spend months revising one study — or could that time have been better spent on publishing multiple smaller studies?...

Though he can't prove it yet, he suspects social science has made a trade-off: Big, time-consuming studies are coming at the cost of smaller and cheaper studies that, taken together, may be just as valuable and perhaps more applicable (or what researchers call "generalizable") to more people and places...

research is complex, and scientific findings may not fit into a neat story — at least not right away. So Rajendran and the staff at Mattershope scientists will be able to share insights in this journal that they may not been able to publish otherwise. He also thinks that if researchers have a place to explore preliminary observations, they may not feel as much pressure to exaggerate their findings in order to add all-important publications to their CVs."

http://www.vox.com/2015/12/14/10048422/matters-journal-small-science-big-data

No comments:

Post a Comment